연구성과로 돌아가기

2020 연구성과별 연구자 정보 (789 / 2428)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Experimental, Structural, and Computational Investigation of Mixed Metal-Organic Frameworks from Regioisomeric Ligands for Porosity Control Yoon, Minyoung Yoon, M 8 교신저자 Kyungpook Natl Univ, Dept Chem, Daegu 41566, South Korea 0000-0001-7436-6273 Yoon, Minyoung myyoon@knu.ac.kr;kim.hyungjun@inu.ac.kr;dwkxtal@kaist.ac.kr;minkim@chungbuk.ac.kr;
Experimental, Structural, and Computational Investigation of Mixed Metal-Organic Frameworks from Regioisomeric Ligands for Porosity Control Kim, Hyungjun Kim, H 9 교신저자 Incheon Natl Univ, Dept Chem, Incheon 22012, South Korea myyoon@knu.ac.kr;kim.hyungjun@inu.ac.kr;dwkxtal@kaist.ac.kr;minkim@chungbuk.ac.kr;
Experimental, Structural, and Computational Investigation of Mixed Metal-Organic Frameworks from Regioisomeric Ligands for Porosity Control Kim, Hyungjun Kim, H 9 교신저자 Incheon Natl Univ, Res Inst Basic Sci, Incheon 22012, South Korea myyoon@knu.ac.kr;kim.hyungjun@inu.ac.kr;dwkxtal@kaist.ac.kr;minkim@chungbuk.ac.kr;
Experimental, Structural, and Computational Investigation of Mixed Metal-Organic Frameworks from Regioisomeric Ligands for Porosity Control Kim, Dongwook Kim, D 10 교신저자 Inst for Basic Sci Korea, Ctr Catalyt Hydrocarbon Functionalizat, Daejeon 34141, South Korea myyoon@knu.ac.kr;kim.hyungjun@inu.ac.kr;dwkxtal@kaist.ac.kr;minkim@chungbuk.ac.kr;
Experimental, Structural, and Computational Investigation of Mixed Metal-Organic Frameworks from Regioisomeric Ligands for Porosity Control Kim, Min Kim, M 11 교신저자 Chungbuk Natl Univ, Dept Chem, Cheongju 28644, South Korea Q-9608-2019 Kim, Min myyoon@knu.ac.kr;kim.hyungjun@inu.ac.kr;dwkxtal@kaist.ac.kr;minkim@chungbuk.ac.kr;
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Satoh, Taroh Satoh, T 1 Osaka Univ, Grad Sch Med, Frontier Sci Canc & Chemotherapy, Suita, Osaka, Japan AAF-5193-2021 Satoh, Taroh nboku@ncc.go.jp;
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Kang, Yoon-Koo Kang, YK 2 Univ Ulsan, Coll Med, Dept Oncol, Asan Med Ctr, Seoul, South Korea ABL-4264-2022 Kang, Yoon-Koo nboku@ncc.go.jp;
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Chao, Yee Chao, Y 3 Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan nboku@ncc.go.jp;
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Ryu, Min-Hee Ryu, MH 4 Univ Ulsan, Coll Med, Dept Oncol, Asan Med Ctr, Seoul, South Korea nboku@ncc.go.jp;
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Kato, Ken Kato, K 5 Natl Canc Ctr, Div Gastrointestinal Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan nboku@ncc.go.jp;
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Cheol Chung, Hyun Chung, HC 6 Yonsei Univ, Yonsei Univ Hlth Syst, Song Dang Inst Canc Res, Yonsei Canc Ctr,Div Med Oncol,Coll Med, Seoul, South Korea AFB-8969-2022 Chung, Hyun Cheol 0000-0002-0920-9471 Chung, Hyun nboku@ncc.go.jp;
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Chen, Jen-Shi Chen, JS 7 Chang Gung Univ, Linkou Chang Gung Mem Hosp, Dept Internal Med, Div Hematol & Oncol, Taoyuan, Taiwan GLV-3349-2022 Chen, Jen-Shi nboku@ncc.go.jp;
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Muro, Kei Muro, K 8 Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan nboku@ncc.go.jp;
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Ki Kang, Won Kang, WK 9 Sungkyunkwan Univ, Samsung Med Ctr, Div Hematol Oncol, Dept Med,Sch Med, Seoul, South Korea nboku@ncc.go.jp;
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Yeh, Kun-Huei Yeh, KH 10 Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan HGD-3316-2022 Yeh, Kun-Huei 0000-0002-7306-174X YEH, Kun-Huei nboku@ncc.go.jp;
페이지 이동: